# US 2024/0002916 A1 · Direct lysis apparatus and methods for molecular diagnostics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002916 A1
- Document ID: US20240002916A1
- Status: Published application
- Kind: A1
- Application number: 18/038,181
- Filed: 2021-11-16
- Published: 2024-01-04
- Earliest claimed: 2020-11-23
- Assignees: Nuclein, LLC
- Applicants: Nuclein, LLC
- Inventors: Richard CROCKETT; Alan BLAKE; Brittan PASLOSKE; Jeffrey SHELTON; Michael KARBERG; Ehren ACHEE; James Doug WEHRLY; Alex ILES; John LUPHER
- Web page: https://patentgrep.com/patent/US20240002916A1

## CPC

- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- B01L 3/502753: {characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation}
- C12Q 1/686: Polymerase chain reaction [PCR]
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/0663: Whole sensors
- B01L 2300/0672: Integrated piercing tool
- B01L 2300/0681: Filter
- B01L 2300/18: Means for temperature control
- B01L 2400/0409: centrifugal forces
- B01L 2400/0478: pistons
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6844: Nucleic acid amplification reactions
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This disclosure relates to direct lysis apparatus and methods for molecular diagnostics. Certain embodiments include a piston cycled from a first position proximal to a first end of a housing, to a second position proximal to a second end of the housing, and back to the first position proximal to the first end of the housing. In some embodiments, the present disclosure relates to devices, methods, and systems for molecular diagnostics that do not comprise a piston.

## Claims

### Claim 1

An apparatus for nucleic acid amplification, the apparatus comprising:
a receptacle configured to receive a sample;
a heater;
an amplification chamber; and
a reaction mix, wherein:
the apparatus is configured to heat the reaction mix to a temperature of at least about and
the apparatus is configured to combine the sample with reaction mix after the reaction mix has been heated to the temperature of at least about 60° C.

### Claim 2 (depends on 1)

The apparatus of claim 1 wherein the apparatus is configured to heat the reaction mix to a temperature of approximately 95° C.

### Claim 3 (depends on 1, 2)

The apparatus of claim 1 or 2 further comprising a diluent.

### Claim 4 (depends on 3)

The apparatus of claim 3 wherein the apparatus is configured:
to heat the diluent and the reaction mix to a temperature of at least about 60° C.; and
the apparatus is configured to combine the sample with the diluent and the reaction mix after the diluent and the reaction mix has been heated to the temperature of at least about 60° C.

### Claim 5 (depends on 4)

The apparatus of claim 4 wherein the apparatus is configured to heat the diluent and the reaction mix to a temperature of approximately 95° C.

### Claim 6 (depends on 1, 2, 3, 4)

The apparatus of any of claims 1-4 further comprising a prefilter.

### Claim 7 (depends on 6)

The apparatus of any of claim 6 wherein the prefilter is configured to filter the sample after the sample is received in the receptacle and prior to the sample being introduced into the amplification chamber.

### Claim 8 (depends on 6)

The apparatus of claim 6 wherein the prefilter is configured to mechanically filter the sample.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The apparatus of any of claims 1-8 wherein the reaction mix comprises a polymerase enzyme.

### Claim 10 (depends on 9)

The apparatus of claim 9 wherein the polymerase enzyme is a thermostable DNA polymerase with reverse transcriptase activity.

### Claim 11 (depends on 9)

The apparatus of claim 9 wherein the thermostable polymerase with reverse transcriptase activity is Tth polymerase.

### Claim 12 (depends on 9)

The apparatus of claim 9 wherein the polymerase enzyme is a thermostable DNA polymerase.

### Claim 13 (depends on 12)

The apparatus of claim 12 wherein the thermostable DNA polymerase is Taq polymerase.

### Claim 14

The apparatus of any preceding claim wherein the reaction mix contains a reducing agent.

### Claim 15 (depends on 14)

The apparatus of claim 14 wherein the reducing agent comprises dithiothreitol (DTT).

### Claim 16 (depends on 14)

The apparatus of claim 14 wherein the reducing agent comprises tris(2-carboxyethyl)phosphine) (TCEP).

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The apparatus of any of claims 1-17 wherein the apparatus is configured to cycle the sample and the reaction mix between a first temperature and a second temperature to amplify nucleic acids in the amplification chamber, wherein the first temperature is a lower temperature than the second temperature.

### Claim 18

The apparatus of any preceding claim wherein the receptacle is configured as a spittoon.

### Claim 19

A method of nucleic acid amplification, the method comprising:
filtering a raw biological sample to provide a filtered biological sample;
heating a reaction mix to a temperature of at least about 60° C. to provide a heated reaction mix; and
combining the filtered biological sample with the heated reaction mix.

### Claim 20 (depends on 1)

The method of claim 1 wherein the reaction mix is heated to a temperature of approximately 95° C.

### Claim 21 (depends on 19, 20)

The method of claim 19 or claim 20 further comprising diluting the filtered biological sample prior to combining the filtered biological sample with the heated reaction mix.

### Claim 22

The method of any of the preceding claims wherein filtering the raw biological sample comprises mechanically filtering the raw biological sample.

### Claim 23

The method of any of the preceding claims wherein the reaction mix comprises a polymerase enzyme.

### Claim 24 (depends on 23)

The method of claim 23 wherein the polymerase enzyme comprises a thermostable DNA polymerase with reverse transcriptase activity.

### Claim 25 (depends on 23)

The method of claim 23 wherein the polymerase enzyme comprises a Tth enzyme.

### Claim 26 (depends on 23)

The method of claim 23 wherein the polymerase enzyme comprises a DNA polymerase.

### Claim 27 (depends on 26)

The method of claim 26 wherein the DNA polymerase comprises a Taq enzyme.

### Claim 28

The method of any preceding claim wherein the reaction mix contains a reducing agent.

### Claim 29 (depends on 28)

The method of claim 28 wherein the reducing agent comprises dithiothreitol (DTT).

### Claim 30 (depends on 28)

The method of claim 28 wherein the reducing agent comprises tris(2-carboxyethyl)phosphine) (TCEP).

### Claim 31

The method of any preceding claim further comprising cycling the filtered sample and the reaction mix between a first temperature and a second temperature to amplify nucleic acids in the filtered sample and reaction mix, wherein the first temperature is a lower temperature than the second temperature.

### Claim 32

An apparatus for nucleic acid amplification, the apparatus comprising:
a mechanical prefilter;
a diluent;
a reaction mix; and
an amplification chamber, wherein:
the diluent and reaction mix are combined into a mixture and raised to a temperature of at least about 60° C.; and
a biological sample is combined with the mixture after it has reached at least about 60° C.

### Claim 33 (depends on 32)

The apparatus of claim 32 where the reaction mix contains a reducing agent.

### Claim 34 (depends on 32, 33)

The apparatus of claim 32 or claim 33 where the reaction mix is lyophilized.
